{"id":597672,"date":"2022-04-26T20:00:02","date_gmt":"2022-04-26T20:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=597672"},"modified":"2022-04-26T20:00:02","modified_gmt":"2022-04-26T20:00:02","slug":"obsessivecompulsive-disorder-market-is-expected-to-showcase-a-significant-growth-by-2032-predicts-delveinsight-key-companies-pfizer-glaxosmithkline-eli-lilly-biohaven-pharma-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/obsessivecompulsive-disorder-market-is-expected-to-showcase-a-significant-growth-by-2032-predicts-delveinsight-key-companies-pfizer-glaxosmithkline-eli-lilly-biohaven-pharma-and-others_597672.html","title":{"rendered":"Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies &#8211; Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1588078163.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1588078163.png\" alt=\"Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Obsessive-Compulsive Disorder Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">The <strong>Obsessive-Compulsive Disorder market report<\/strong> covers emerging drugs, current treatment practices, market share of the individual therapies, and current &amp; forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers &amp; barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" title=\"Obsessive-Compulsive Disorder Market\" src=\"https:\/\/www.abnewswire.com\/uploads\/2fd24aeddfb8297b896bca9521ed62a4.jpg\" alt=\"Obsessive-Compulsive Disorder Market\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Obsessive-Compulsive Disorder: An Overview<\/strong><\/p>\n<p style=\"text-align: justify;\"><em>Obsessive-Compulsive Disorder (OCD) is an anxiety disorder in which people get recurring, unwanted thoughts, ideas, or sensations (obsessions) that make them feel driven to do something repetitively (compulsions). It is associated with a profoundly diminished quality of life, social isolation, and a substantial economic burden on society.<\/em><\/p>\n<p style=\"text-align: justify;\"><em>As per the World Health Organization&rsquo;s &lsquo;Depression and other common mental disorders&rsquo; report (2017), the&nbsp;OCD was included in the &lsquo;anxiety disorders&rsquo; category. Obsessive-Compulsive Disorder ranks tenth in the World Bank&rsquo;s and WHO&rsquo;s ten leading causes of disability and, in the case of women aged 15&ndash;44 years, Obsessive-Compulsive Disorder occupies the fifth position.<\/em><\/p>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder Market Key Facts<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><em>According to NIMH, Obsessive-Compulsive Disorder currently affects approximately 1 in 40 adults and 1 in 100 children in the U.S.<\/em><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><em>As per the study conducted by Nakajima A. et al.,(2018), Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan.&nbsp;<\/em><em><br \/><\/em><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\"><strong>Obsessive-Compulsive Disorder Market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted <strong>Obsessive-Compulsive Disorder market size<\/strong> by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers &amp; barriers, unmet needs, and emerging technologies.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The report gives complete detail of the <strong>Obsessive-Compulsive Disorder market trend<\/strong> for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Obsessive-Compulsive Disorder Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The epidemiology section covers insights into the historical and current <strong>Obsessive-Compulsive Disorder patient pool and forecasted trends<\/strong> for every seven major countries (7MM)&nbsp; from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Obsessive-Compulsive Disorder Drugs Uptake and Pipeline Development Activities<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the <strong>Obsessive-Compulsive Disorder market<\/strong> or expected to get launched during the study period. The analysis covers the Obsessive-Compulsive Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The report also covers the <strong>Obsessive-Compulsive Disorder Pipeline Development Activities<\/strong>. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Request for Sample PDF Report &#8211;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Obsessive-Compulsive Disorder Therapeutics Analysis<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><em>The Obsessive-Compulsive Disorder market size is anticipated to grow in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of the emerging therapies.<\/em><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the key players in the Obsessive-Compulsive Disorder market include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Pfizer<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">GlaxoSmithKline<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Eli Lilly and Company<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Biohaven Pharmaceuticals<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Obsessive-Compulsive Disorder Therapies Covered in the report include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">ZOLOFT<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Paxil<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">PROZAC<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Trigriluzole<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Get More Detailed Insights Into the Emerging Therapies &amp; Key Companies &#8211;&nbsp; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Content (TOC)<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">2. Executive Summary&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">3. Obsessive-Compulsive Disorder Competitive Intelligence Analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">4. Obsessive-Compulsive Disorder Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">5. Obsessive-Compulsive Disorder Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">6. Obsessive-Compulsive Disorder Patient Journey<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">7. Obsessive-Compulsive Disorder Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">8. Obsessive-Compulsive Disorder Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">9. Obsessive-Compulsive Disorder Unmet Needs<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">10. Key Endpoints of Obsessive-Compulsive Disorder Treatment<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">11. Obsessive-Compulsive Disorder Marketed Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">12. Obsessive-Compulsive Disorder Emerging Therapies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">13. Obsessive-Compulsive Disorder Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">14. Attribute Analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">15. Obsessive-Compulsive Disorder Market Outlook (7 major markets)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">16. Obsessive-Compulsive Disorder Access and Reimbursement Overview<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">17. KOL Views on the Obsessive-Compulsive Disorder Market.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">18. Obsessive-Compulsive Disorder Market Drivers<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">19. Obsessive-Compulsive Disorder Market Barriers<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">20. Appendix<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><em>*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.<\/em><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Download Sample PDF Report &#8211;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Other Latest Reports By DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/renal-vasculitis-market\">Renal Vasculitis Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s &ldquo;<strong>Renal Vasculitis Market<\/strong>&rdquo; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, Renal Vasculitis market size, share, trends in the 7MM as well as the emerging therapies, and key companies actively working in the domain.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75613.html\" rel=\"nofollow\">DelveInsight Business Research<\/a><br \/><strong>Contact Person:<\/strong> Shruti Thakur<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=obsessivecompulsive-disorder-market-is-expected-to-showcase-a-significant-growth-by-2032-predicts-delveinsight-key-companies-pfizer-glaxosmithkline-eli-lilly-biohaven-pharma-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304  S. Jones Blvd #2432<br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=obsessivecompulsive-disorder-market-is-expected-to-showcase-a-significant-growth-by-2032-predicts-delveinsight-key-companies-pfizer-glaxosmithkline-eli-lilly-biohaven-pharma-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delveinsight Business Research LLP DelveInsight&#8217;s &#8220;Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Obsessive-Compulsive Disorder Market Size and Share in the 7MM (i.e., &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/obsessivecompulsive-disorder-market-is-expected-to-showcase-a-significant-growth-by-2032-predicts-delveinsight-key-companies-pfizer-glaxosmithkline-eli-lilly-biohaven-pharma-and-others_597672.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[426,405,410,417,406],"tags":[],"class_list":["post-597672","post","type-post","status-publish","format-standard","hentry","category-Financial-Market","category-Health-Medicine","category-Manufacturing-Industry","category-Marketing-Sales","category-Pharmaceuticals-Biotech"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/597672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=597672"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/597672\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=597672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=597672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=597672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}